VAERS 2021 Database www.vaers.hhs.gov

Main Page | All 2021 Deaths | Videos
VAERS Updated: 11/12/2021
** VAERS DATABASE Last updated: November 12, 2021**
PLEASE CHECK BACK SOON
Download the files above while you wait.







Manufacturers

Total Manufacturer
46,870MODERNA
532GLAXOSMITHKLINE BIOLOGICALS
353PFIZER\BIONTECH
231MERCK & CO. INC.
221UNKNOWN MANUFACTURER
62SEQIRUS, INC.
25DYNAVAX TECHNOLOGIES CORPORATION
13EMERGENT BIOSOLUTIONS
12SANOFI PASTEUR
9NOVARTIS VACCINES AND DIAGNOSTICS
5PFIZER\WYETH
5PAXVAX
2TEVA PHARMACEUTICALS
2PROTEIN SCIENCES CORPORATION
1BERNA BIOTECH, LTD.
1INTERCELL AG
1CSL LIMITED

COVID19 Lot Number

VAX LOT Total
2S9CL1,906
1,575
289
IMM209286
252
236
229
s029456178
171
UT7065MA166
155
149
145
S034636133
107
U62828AA103
100
98
P10025327596
U6737AA85
UJ446AA79
78
78
59
57
4BH3254
4F47253
52
27656352
50
PP9L548
49TM346
42
40
38
MENVEO38
4F47237
R1B252M36
34
C5763AA30
93362229
25
300057A24
UNK24
22
CW311621
18
17
15
UH894AB15
3Y7NL12
R1B743M12
EJ168611
el128410
10
10
10
9
ARBA141A9
UNK9
8
UNK8
8
1F4EB8
Unknown7
7
No batch number6
5
5
UJ090AA5
5
5
4
4
4
UNK4
JEV18K95E4
UNK3
A115A3
Z127A3
3
3333324181073
2
2
2
TAR352
1
1
1
1
1
A739081
1
1
1
1
1
037K20A68,542
EL128447,700
133

Incidents per State

State Total
15,185
CA14,096
NY7,507
TX7,196
FL6,939
IN5,527
PA4,560
IL4,179
OH4,054
AZ3,856
MI3,771
NJ3,411
MA3,278
VA3,208
NC3,114
WA3,034
GA2,864
MD2,652
MN2,534
CO2,532
WI2,457
MO2,029
OR1,943
TN1,715
CT1,693
KY1,603
OK1,226
AL1,201
KS1,162
IA1,157
SC1,106
NM1,065
UT973
AR951
LA945
NE829
NV797
ME795
MT789
NH756
ID674
AK661
WV661
PR650
MS585
HI536
RI510
VT441
SD361
ND356
DE350
DC239
WY209
GU32
AS16
VI13
MP9
MH3
FM2
QM1
XB1

ID: 1018954
Sex: M
Age:
State:

Vax Date:
Onset Date: 01/25/2021
Rec V Date: 02/10/2021
Hospital:

Lab Data:

Allergies:

Symptoms: congestion in his ears, nose and throat. He went to the ER; congestion in his ears, nose and throat. He went to the ER; congestion in his ears, nose and throat. He went to the ER; This is a Spontaneous report from a Pfizer sponsored program. A contactable consumer (patient) reported that a male patient of an unspecified age received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration on an unspecified date (reported as 'Saturday') at single dose for covid-19 immunization. The patient's medical history and concomitant medications were not reported. The patient got the Covid vaccine on Saturday and last night (25Jan2021) he started to get congestion in his ears, nose and throat. He went to the ER this morning and they told him it could be side effects from getting the Covid vaccine. He needed to know for work how long the side effects could last. The outcome of the events was unknown Information on the Lot/Batch number has been requested.

Other Meds:

Current Illness:

ID: 1018955
Sex: U
Age:
State: CA

Vax Date:
Onset Date: 12/23/2020
Rec V Date: 02/10/2021
Hospital:

Lab Data:

Allergies:

Symptoms: chills; This is a spontaneous report from two contactable consumers. A patient of unspecified age and gender received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration on an unspecified date at single dose for COVID-19 immunization. The patient medical history and concomitant medications were not reported. The patient experienced chills on 23Dec2020. The patient outcome of the events was recovered. No follow-up attempts are possible, information about batch number cannot be obtained.

Other Meds:

Current Illness:

ID: 1018956
Sex: F
Age: 35
State: HI

Vax Date: 02/09/2021
Onset Date: 02/09/2021
Rec V Date: 02/10/2021
Hospital:

Lab Data: NOne

Allergies: environmental, questionable MSG

Symptoms: Patient complained of pressure behind left eye, small headache. Rates pain 3/10 on 0-10 pain scale. Gradual onset. Patient reports she is not in much discomfort. Intends to continue with her errands after she is released. Monitored, discussed seeking additional medical assistance if headache did not subside or got worse. Patient expressed understanding. Released from post-vaccination area at 12:45pm

Other Meds: emprozole prn; zentrizine prn

Current Illness: None

ID: 1018957
Sex: F
Age:
State: OH

Vax Date: 11/01/2020
Onset Date: 11/17/2020
Rec V Date: 02/10/2021
Hospital:

Lab Data:

Allergies:

Symptoms: allergic reaction; This is a spontaneous report from a contactable consumer (patient) via a Pfizer-sponsored program. A 78-year-old female patient started to receive pneumococcal 13-val conj vac (dipht crm197 protein) (PREVNAR 13, lot/batch number not reported), via an unspecified route of administration on an unspecified date in Nov2020 at single dose for immunisation. The patient medical history and concomitant medications were not reported. Patient had an allergic reaction to pneumococcal 13-val conj vac (dipht crm197 protein) vaccine last 17Nov2020. The outcome of event was unknown. No follow-up attempts are needed, information about lot/batch number cannot be obtained.

Other Meds:

Current Illness:

ID: 1018958
Sex: F
Age:
State: AR

Vax Date: 01/05/2021
Onset Date:
Rec V Date: 02/10/2021
Hospital:

Lab Data:

Allergies:

Symptoms: Almost going to pass out; she sees the room as color yellow and red; sweat breakouts; This is a spontaneous report from a Pfizer-sponsored program reported from a contactable consumer (patient's mother). A 40-year-old female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration on 05Jan2021 at single dose for COVID-19 immunisation. Patient age at vaccination was 40 years. The patient's medical history and patient's concomitant medications were not reported. The reporter stated the patient had COVID-19 vaccine 3 weeks ago and she will have the 2nd dose of vaccine 'tomorrow'. The reporter was kind of nervous about her getting the 2nd dose as the patient is experiencing a sweat breakouts and almost going to pass out, she sees the room as color yellow and red. The outcome of the events was unknown. Information on the lot/batch number has been requested.

Other Meds:

Current Illness:

ID: 1018959
Sex: F
Age:
State: IN

Vax Date: 01/03/2021
Onset Date: 01/01/2021
Rec V Date: 02/10/2021
Hospital:

Lab Data:

Allergies:

Symptoms: heart started beating fast; lumps grow up on my arm; short of breath; kind of weak; uncomfortable feeling; This is a spontaneous report from a Pfizer sponsored program. A contactable nurse (patient) reported a 41-year-old female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: EL1284) via unspecified route on right deltoid single dose for COVID-19 immunization on 03Jan2021, at 41-year-old. No medical history. Concomitant medication was reported but unspecified. After the patient had received the shot (Jan2021), her heart started beating fast, felt lumps grow up on her arm and became little short of breath. That went away rather quickly, about within 3 hours and the patient was still kind of weak and just uncomfortable feeling. Action taken for BNT162B2 was not applicable. Outcome of the events heart started beating fast, lumps grow up on her arm, short of breath was resolved in Jan2021; outcome of the other events was unknown. Causality assessment per the reporter was checked as yes.

Other Meds:

Current Illness:

ID: 1018960
Sex: M
Age:
State:

Vax Date: 01/15/2020
Onset Date: 09/01/2020
Rec V Date: 02/10/2021
Hospital:

Lab Data:

Allergies:

Symptoms: Myocarditis and Angina pectoris

Other Meds:

Current Illness:

ID: 1018961
Sex: F
Age:
State:

Vax Date:
Onset Date:
Rec V Date: 02/10/2021
Hospital:

Lab Data:

Allergies:

Symptoms: heart condition; This is a spontaneous report from a contactable consumer (patient). A female patient with age of 75 (unknown unit) received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration on an unspecified date at single dose for covid-19 immunisation. The patient medical history was not reported. Concomitant medication included paracetamol (TYLENOL), apixaban (ELIQUIS), lisinopril, metoprolol, ascorbic acid; betacarotene; chromium picolinate; lycopene; mecobalamin; pyridoxine; retinol acetate; riboflavin; thiamine; tocopheryl acetate; vitamin b12 nos; xantofyl; zinc sulfate (OPTIVITE), clopidogrel bisulfate (PLAVIX), cyanocobalamin (VITAMIN B12 [CYANOCOBALAMIN]). Patient stated she had a heart condition and had caner. Caller asked if she can use antipyretics before or after vaccination? Caller stated her daughter told her that paracetamol makes the vaccine less effective. Information on the lot/batch number has been requested.

Other Meds: TYLENOL; ELIQUIS; LISINOPRIL; METOPROLOL; OPTIVITE; PLAVIX; VITAMIN B12 [CYANOCOBALAMIN]

Current Illness:

ID: 1018962
Sex: M
Age: 63
State: TX

Vax Date: 01/06/2021
Onset Date: 01/06/2021
Rec V Date: 02/10/2021
Hospital:

Lab Data: None

Allergies: None

Symptoms: Fever 101 F; rigors; chills; malaise; nausea; anorexia; arthralgias; myalgia; 36 hours duration Ibuprofen; hydration; bed rest; Work absenteeism x 3 days

Other Meds: Losartan, hydrochlorothiazide, Tamsulosin

Current Illness: None

ID: 1018963
Sex: F
Age:
State: CO

Vax Date: 01/02/2021
Onset Date: 01/03/2021
Rec V Date: 02/10/2021
Hospital:

Lab Data:

Allergies:

Symptoms: Headache; Myalgia; Chills; Lymphadenopathy; Brain fog; This is a spontaneous report from a contactable physician (patient). A 45-year-old female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number Ek9231) via intramuscular in left arm on 02Jan2021 18:00 at single dose for COVID 19 immunization. The patient received the vaccine in hospital. Medical history included asthma, migraine. Known allergies included Latex allergy. Concomitant medication included oral contraceptive pill (OCP), ergocalciferol (VIT D), melatonin, ubidecarenone (COQ10) and fexofenadine hydrochloride (ALLEGRA). No other vaccine was received in four weeks. The patient didn't have COVID prior vaccination. The patient experienced headache, brain fog, myalgia, chills, lymphadenopathy on 03Jan2021. Therapeutic measures were taken as a result of events including ibuprofen (MOTRIN). The events did not require Emergency Room Visit or Physician Office Visit. No COVID was test post vaccination. The outcome of events was recovered in Jan2021.

Other Meds: VIT D; MELATONIN; ALLEGRA; COQ10 [UBIDECARENONE]

Current Illness:

ID: 1018964
Sex: F
Age:
State: TX

Vax Date: 01/20/2021
Onset Date: 01/20/2021
Rec V Date: 02/10/2021
Hospital:

Lab Data:

Allergies:

Symptoms: I felt dizzy; nauseated; This is a spontaneous report from a non-contactable consumer (patient). This 65-year-old female patient received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE) (Lot# EL9261), via an unspecified route of administration on 20Jan2021 14:15 at single dose on the right arm for COVID-19 immunization. The patient medical history was none. No known allergies. The patient's concomitant medications were not reported. No other vaccine received in four weeks. Within 15 mins of being vaccinated, patient felt dizzy and nauseated. Patient believed these symptoms would have been less severe had she eaten something and drunk sufficient fluids prior to the injection. The symptoms went away within a couple of hours after eating and drinking. No COVID prior vaccination. No COVID tested post vaccination. No treatment received. Outcome of the events was recovered in Jan2021. No follow-up attempts are possible. No further information is expected.

Other Meds:

Current Illness:

ID: 1018965
Sex: F
Age:
State: NJ

Vax Date: 01/19/2021
Onset Date: 01/20/2021
Rec V Date: 02/10/2021
Hospital:

Lab Data: Test Date: 20210122; Test Name: Nasal Swab; Test Result: Negative

Allergies:

Symptoms: Charlie horses in legs; multiple cold sores on lip; Chills; Fatigue; headache; cold sweats; This is a spontaneous report from a contactable nurse (patient herself). A 59-year-old non-pregnant female patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: unable to locate or read the details), via an unspecified route of administration on 19Jan2021 13:00 at single dose in right arm for COVID-19 immunization. Medical history included psoriasis, high blood pressure, thyroid removal. The patient had no Known allergies. The patient other concomitant medications in two weeks included guselkumab (TREMFYA), levothyroxine sodium (SYNTHROID), aspirin (acetylsalicylic acid), bupropion hydrochloride (WELLBUTRIN), nebivolol hydrochloride (BYSTOLIC). Prior vaccination, the patient had not had COVID, not tested post vaccination. No other vaccine in four weeks. The patient previously took the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number unknown), via an unspecified route of administration on 19Dec2020 at 12:00 PM at single dose in right arm for COVID-19 immunization. The patient experienced charlie horses in legs, multiple cold sores on lip, chills, fatigue, headache, cold sweats on 20Jan2021 07:00. The patient did not received treatment for events. The patient underwent lab tests and procedures which included sars-cov-2 test: negative on 22Jan2021. The outcome of the events charlie horses in legs, multiple cold sores on lip, chills, fatigue, headache, cold sweat was recovered in Jan2021. Information on the Lot/Batch number has been requested.

Other Meds: TREMFYA; SYNTHROID; ASPIRIN [ACETYLSALICYLIC ACID]; WELLBUTRIN; BYSTOLIC

Current Illness:

ID: 1018966
Sex: M
Age:
State: NY

Vax Date: 01/19/2021
Onset Date: 01/21/2021
Rec V Date: 02/10/2021
Hospital:

Lab Data:

Allergies:

Symptoms: Aphthous Ulcer; This is a spontaneous report from a contactable physician for himself. A 29-years-old male patient received the second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: EC4248), via an unspecified route of administration on left arm on 19Jan2021 at SINGLE DOSE for covid-19 immunisation. The patient medical history reported as none. The patient's concomitant medications were not reported. The patient previously took aspirin [acetylsalicylic acid] and experienced drug hypersensitivity. The patient took the first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: EK9231), via an unspecified route of administration on left arm on 29Dec2020 02:45 PM at single dose for covid-19 immunisation. The patient experienced aphthous ulcer on 21Jan2021 12:00 with outcome of not recovered. No treatment received. No Covid prior vaccination. No Covid tested post vaccination.

Other Meds:

Current Illness:

ID: 1018967
Sex: F
Age:
State:

Vax Date: 01/15/2021
Onset Date: 01/20/2021
Rec V Date: 02/10/2021
Hospital:

Lab Data:

Allergies:

Symptoms: Fever; Headache; Vomiting; This is a spontaneous report from a non-contactable consumer, the patient. This 72-year-old female patient received BNT162B2 (Pfizer-BioNTech COVID-19 mRNA vaccine) (Lot number: Unknown), via an unspecified route of administration on 15Jan2021 (at the age of 72-years-old) as a single dose for COVID-19 vaccination. The patient's medical history was not reported. There were no known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient was not pregnant at the time of vaccination. The patient's concomitant medications were not reported. On 20Jan2021, the patient experienced fever, headache and vomiting 5 days after vaccination. No therapeutic measures were taken as a result of the events. The clinical outcomes of the fever, headache and vomiting were resolving. It was also reported that since the vaccination, the patient had not been tested for COVID-19. No follow-up attempts are possible; information about lot/batch number cannot be obtained.

Other Meds:

Current Illness:

ID: 1018968
Sex: F
Age:
State: PA

Vax Date: 01/20/2021
Onset Date: 01/01/2021
Rec V Date: 02/10/2021
Hospital:

Lab Data:

Allergies:

Symptoms: rash worsened following the 2nd injection. Rash then spread all over body and increased in size; Extremely itchy; Diagnosed as possible pityriasis; This is a spontaneous report from a contactable nurse (patient). A 28-year-old female patient received 2nd dose of BNT162B2 (lot number: EL3249), via an unspecified route of administration in left arm on 20Jan2021 13:45 at single dose for covid-19 immunisation. Medical history known allergies: eggs, shellfish, peanuts. Concomitant medication included desogestrel, ethinylestradiol (APRI). The patient previously received 1st dose of BNT162B2 (lot number: EL0140) in left arm on 30Dec2020 for COVID-19 immunization and experienced rash/mainly on stomach two days after the 1st injection. On an unspecified date of Jan2021, the rash worsened following the 2nd injection. Rash then spread all over body and increased in size. Extremely itchy. Diagnosed as possible pityriasis. Treatment steroid cream received for the adverse events. The outcome of events was not recovered. This case was reported as non-serious. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The adverse events result in doctor or other healthcare professional office/clinic visit. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient has not been tested for COVID-19.

Other Meds: APRI

Current Illness:

ID: 1018969
Sex: F
Age:
State: CA

Vax Date: 01/19/2021
Onset Date: 01/19/2021
Rec V Date: 02/10/2021
Hospital:

Lab Data:

Allergies:

Symptoms: Cold; Shivering; Fatigue; This is a spontaneous report from a non-contactable other health professional (patient). A 48-year-old non-pregnant female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration on 19Jan2021 19:00 at left arm, at single dose for covid-19 immunization. Medical history included autoimmune disorder, spinal stenosis, pre-Diabetic. Known allergies was yes. The patient's concomitant medications were not reported. No other medications in two weeks. The patient experienced shivering 8 hrs later at 20Jan2021 03:00 and fatigue immediately after 1 hr of vaccine at 19Jan2021 20:00 and 3 days later cold and fatigue on 22Jan2021. No treatment was received for all events. The outcome o the events was recovered in Jan2021. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. No follow-up attempts are possible; Information about lot/batch number cannot be obtained. No further information expected.

Other Meds:

Current Illness:

ID: 1018970
Sex: F
Age:
State: AZ

Vax Date: 01/22/2021
Onset Date: 01/22/2021
Rec V Date: 02/10/2021
Hospital:

Lab Data: Test Date: 20210122; Test Name: heart rate; Result Unstructured Data: Test Result:Increased

Allergies:

Symptoms: Increased heart rate; slight lightheaded; headache; sore arm and neck; sore arm and neck; extreme lethargy; This is a spontaneous report from a contactable other-healthcare professional (patient). A 31-year-old female patient (not pregnancy) received the first dose of BNT162B2 (Pfizer-BIONTECH Covid-19 Vaccine, lot number: EL9263), via an unspecified route of administration at site of left arm at 15:00 on 22Jan2021 at single dose for covid-19 immunization. Medical history included bursitis, chronic migraines, high blood pressure and fibromyalgia. Concomitant medication included methocarbamol, colecalciferol (VITAMIN D), loratadine and omeprazole, all received in two weeks of vaccination. The patient experienced increased heart rate, slight lightheaded, headache, sore arm and neck, extreme lethargy at 15:30 on 22Jan2021. No other vaccine received in four weeks. Adverse reactions did not result any serious consequences. No treatment received for adverse event. No Covid prior vaccination. No Covid tested post vaccination. Not known allergies. The outcome of events was recovering.

Other Meds: METHOCARBAMOL; VITAMIN D [COLECALCIFEROL]; LORATADINE; OMEPRAZOLE

Current Illness:

ID: 1018971
Sex: F
Age:
State: CT

Vax Date: 01/04/2021
Onset Date: 01/04/2021
Rec V Date: 02/10/2021
Hospital:

Lab Data:

Allergies:

Symptoms: fever; chills; weakness; rash all over the body; sob; This is a spontaneous report from a contactable nurse (patient). A 45-year-old female patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), intramuscular in arm left on 04Jan2021 08:45 at single dose for COVID-19 immunization. The patient was not pregnant at time of vaccination. Medical history included asthma, obesity. Concomitant medication included ascorbic acid (VITAMIN C), colecalciferol (VITAMIN D), fluticasone furoate, vilanterol trifenatate (BREO ELLIPTA), macrogol 3350 (MIRALAX), montelukast sodium (SINGULAIR). The patient previously took cefalexin (KEFLEX) and experienced Known allergies: Keflex. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient did not have COVID tested post vaccination and did not have COVID prior vaccination. The patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) on 18Dec2020 01:30 PM Intramuscular in right arm for COVID-19 immunization. The patient experienced fever, chills, weakness, rash all over the body, sob all on 04Jan2021 12:00 with outcome of recovered in Jan2021. No treatment was received. Information on the Batch/Lot number has been requested.

Other Meds: VITAMIN C [ASCORBIC ACID]; VITAMIN D [COLECALCIFEROL]; BREO ELLIPTA; MIRALAX; SINGULAIR

Current Illness:

ID: 1018972
Sex: F
Age:
State: MT

Vax Date: 12/18/2020
Onset Date: 12/18/2020
Rec V Date: 02/10/2021
Hospital:

Lab Data:

Allergies:

Symptoms: Rash within an hour on neck, chest, wrists, knees, ankles.; Significantly swollen lymph node at base of neck and subclavicular lymph node on side of injection within 2 days.; Body aches; diarrhea; Swelling over anterior and posterior deltoid above site of injection, swelling across clavicle on side of injection within 3-4 days after injection; Swelling over anterior and posterior deltoid above site of injection, swelling across clavicle on side of injection within 3-4 days after injection; This is a spontaneous report from a non-contactable nurse (patient). A 50-year-old non-pregnant female patient received first dose of bnt162b2 (Pfizer-BioNTech COVID-19 mRNA vaccine, lot number: EK5730), via an unspecified route of administration started on 18Dec2020 18:15 at a single dose in left arm (as reported) for COVID-19 immunization. Medical history included chronic autoimmune inflammatory disorder, autoimmune hypothyroid, polycystic ovarian syndrome (PCOS), Raynauds, asthma, fibromyalgia. There were known allergies: some preservatives, several antibiotics, multiple foods. No Pregnant at the time of vaccination. Concomitant medication included loratadine (CLARITIN), famotidine, ergocalciferol (VIT D), nortriptyline, valaciclovir hydrochloride (VALTREX), received within 2 weeks of vaccination. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. On 18Dec2020 19:00, the patient experienced rash within an hour on neck, chest, wrists, knees, ankles. significantly swollen lymph node at base of neck and subclavicular lymph node on side of injection within 2 days. body aches, diarrhea x 1 day. swelling over anterior and posterior deltoid above site of injection, swelling across clavicle on side of injection within 3-4 days after injection. Treatment, including ibuprofen (ADVIL), famotidine, clarithromycin (CLARITIN), heat, was received for adverse events. No COVID tested post vaccination. Since the vaccination, the patient was not tested for COVID-19. This is a non-serious report. The adverse event did not result in 'doctor or other HCP visit or emergency room or urgent care, hospitalization or prolongation, life threatening illness, disability or death or congential anomaly'. The outcome of events was recovering. No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.

Other Meds: CLARITIN [LORATADINE]; FAMOTIDINE; VIT D; NORTRIPTYLINE; VALTREX

Current Illness:

ID: 1018973
Sex: U
Age:
State: FL

Vax Date:
Onset Date:
Rec V Date: 02/10/2021
Hospital:

Lab Data:

Allergies:

Symptoms: Body aches like with the flu; This is a spontaneous report from a contactable consumer. A patient of unspecified age and gender received COVID-19 vaccine (UNSPECIFIED TRADE NAME, lot number: unknown) single dose via unspecified route of administration on an unknown date for COVID-19 vaccination. Medical history and concomitant medications were unknown. On an unknown date, the patient experienced body aches like with the flu for three days. Treatment for the event was unknown. The clinical outcome of body aches like with the flu was recovered on an unknown date. The lot number for the vaccine, BNT162B2, was not provided and will be requested during follow up.

Other Meds:

Current Illness:

ID: 1018974
Sex: F
Age:
State: ME

Vax Date: 01/21/2021
Onset Date: 01/22/2021
Rec V Date: 02/10/2021
Hospital:

Lab Data:

Allergies:

Symptoms: Severe pain from base of skull down spine to mid back. Can't turn head or move without pain.; Severe pain from base of skull down spine to mid back. Can't turn head or move without pain.; This is a spontaneous report from a contactable Other Health Professional (patient). A 36-year-old female patient not pregnant received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number=BL), intramuscularly in left arm on 21Jan2021 19:15 at single dose for COVID-19 immunization. Facility type vaccine: Hospital. Medical history included Known allergies: Latex, morphine, Possible MS. Concomitant medication in two weeks included Phentermine, vitamin D NOS (VITAMIN D), Vitamin B12 NOS (VITAMIN B12), probiotics, multivitamin. If other vaccine in four weeks: No. The patient experienced severe pain from base of skull down spine to mid back. can't turn head or move without pain on 22Jan2021 17:00 with outcome of not recovered. If treatment AE: No. If covid prior vaccination: No. If covid tested post vaccination: No.

Other Meds: PHENTERMINE; VITAMIN D [VITAMIN D NOS]; VITAMIN B12 [VITAMIN B12 NOS]

Current Illness:

ID: 1018975
Sex: F
Age:
State: FL

Vax Date: 01/14/2021
Onset Date: 01/15/2021
Rec V Date: 02/10/2021
Hospital:

Lab Data:

Allergies:

Symptoms: After 1st COVID-19 injection started with vaginal discharge spotting; This is a spontaneous report from a contactable consumer (patient). A 67-year-old non-pregnant female patient received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: EJ1686), via an unspecified route of administration in left arm on 14Jan2021 at single dose for covid-19 immunization at doctor's office/urgent care. Medical history included cirrhosis of liver, diabetes, there was no known drug allergies. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient did not underwent for COVID-19 test. Concomitant medication included oxycodone in two weeks. There was no other vaccine in four weeks. After 1st covid-19 injection the patient started with vaginal discharge spotting on 15Jan2021 16:00. The event resulted in doctor or other healthcare professional office/clinic visit. There was no treatment for the event. The outcome of the event was not resolved.

Other Meds: OXYCODONE

Current Illness:

ID: 1018976
Sex: F
Age:
State: IN

Vax Date: 01/22/2021
Onset Date: 01/22/2021
Rec V Date: 02/10/2021
Hospital:

Lab Data:

Allergies:

Symptoms: Painful left axillary lymphadenopathy (1.5 x 2 inch); Fever; Chills; Sweats; Body aches; Headache; Fatigue; This is a spontaneous report from a contactable physician (patient). A 32-year-old female patient received second dose of bnt162b2 (Solution for injection, lot number: EL1283), intramuscularly at Left arm on 22Jan2021 10:00 at single dose for COVID-19 immunisation. Medical history included subclinical hypothyroidism and allergies to penicillin from an unknown date. The patient is not pregnant. Concomitant medication included levothyroxine. The patient previously took first dose of bnt162b2 on 02Jan2021 09:00 AM at 32-year-old Intramuscularly at left arm; took BACTRIM and experienced allergies to BACTRIM. No other vaccine in four weeks. No COVID prior vaccination. No COVID tested post vaccination. The patient experienced painful left axillary lymphadenopathy (1.5 x 2 inch), fever, chills, sweats, body aches, headache, fatigue from 22Jan2021 10:00 PM. No treatment. The outcome of the events was recovering. Information on the batch/lot number has been requested.

Other Meds: LEVOTHYROXINE

Current Illness:

ID: 1018977
Sex: M
Age:
State:

Vax Date: 01/11/2021
Onset Date: 01/13/2021
Rec V Date: 02/10/2021
Hospital:

Lab Data:

Allergies:

Symptoms: Erythema and pruritus at site, about 8cm in diameter; Erythema and pruritus at site, about 8cm in diameter; This is a spontaneous report from a non-contactable physician (patient). A 31-year-old male patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) Lot number EJ1686, on 11Jan2021 at single dose for COVID-19 immunization. Medical history and concomitant medications were not reported. The patient previously received first dose of BNT162B2 on 19Dec2020. The patient had no other vaccine in four weeks. The patient had no covid prior vaccination. The patient had no Covid tested post vaccination. The patient had no Known Allergies. The patient had Erythema and pruritus at site, about 8cm in diameter on 13Jan2021. No treatment was received for the events. The outcome of the events was resolved. No follow up attempts are possible. No further information is expected.

Other Meds:

Current Illness:

ID: 1018978
Sex: F
Age:
State: MA

Vax Date: 01/09/2021
Onset Date: 01/10/2021
Rec V Date: 02/10/2021
Hospital:

Lab Data: Test Date: 20201222; Test Name: covid test (Nasal Swab); Test Result: Negative

Allergies:

Symptoms: sore arm (briefer than with #1); malaise; fatigue; Pulsing tinnitus, eased off now; bad headache (prexisisting but markedly amplified-still; chills (no fever, 3 days for real, now fading); mild nausea/loss of appetite (largely resolved.); mild nausea/loss of appetite (largely resolved.); This is a spontaneous report from a contactable Physician reported for herself. This 57-year-old female patient (not pregnant) received the second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) on an 09Jan2021 09:00 AM on Arm left at single dose (Lot # EK9231) for covid-19 immunisation. Medical history included Pacemaker, Insomnia, and some preexisting hearing loss, due to effusion. No known allergies. No covid prior vaccination. The patient previously received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) on 19Dec2020 16:45 PM on Left arm at single dose (Lot # EH9899) for covid-19 immunisation. Covid test after #1 (December) due to sore arm, chills, aches and malaise. Was negative. No other vaccine in four weeks. Concomitant medications included other medications in two weeks. The patient experienced pulsing tinnitus, eased off now, also sore arm (briefer than with #1), malaise/fatigue (still but better), bad headache (persisting but markedly amplified-still, chills (no fever, 3 days for real, now fading), mild nausea/loss of appetite (largely resolved.) Events all on 10Jan2021 06:00 AM. Lab data included covid test (Nasal Swab) on 22Dec2020: negative. No treatments were received for the events. Outcome of events mild nausea/loss of appetite, malaise, fatigue was recovering. Outcome of the event chills (no fever, 3 days for real, now fading) was recovered. Outcome of the events was unknown.

Other Meds:

Current Illness:

ID: 1018979
Sex: F
Age:
State: MA

Vax Date: 12/19/2020
Onset Date: 12/01/2020
Rec V Date: 02/10/2021
Hospital:

Lab Data: Test Date: 20201222; Test Name: covid test (Nasal Swab); Test Result: Negative

Allergies:

Symptoms: sore arm; Chills; aches; malaise; This is a spontaneous report from a contactable physician reported for herself. A 57-years-old female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) (lot number: EH9899), via an unspecified route of administration in left arm on 19Dec2020 16:45 at single dose for COVID-19 immunization. Medical history included pacemaker, insomnia and some preexisting hearing loss, no known allergies. Concomitant medications included unspecified medication received in two weeks. The patient was no pregnant. There was no other vaccine received at the same date of the product and in four weeks. The patient had no COVID prior vaccination. The patient experienced sore arm on an unspecified date, chills, aches and malaise in Dec2020. COVID test (Nasal Swab) post vaccination on 22Dec2020 due to chills, aches and malaise was negative. No treatment received for the events. The outcome of the events was unknown.

Other Meds:

Current Illness:

ID: 1018980
Sex: M
Age:
State:

Vax Date: 01/21/2021
Onset Date: 01/23/2021
Rec V Date: 02/10/2021
Hospital:

Lab Data:

Allergies:

Symptoms: 40 hours after receiving vaccine, awoke with night sweats. Felt find otherwise. Went back to sleep and fine in morning.; This is a spontaneous report from a non-contactable consumer. This 67-year-old male consumer (patient) received BNT162B2 (lot number=EL3249) on 21Jan2021 11:30 AM at single dose on Left arm for covid-19 immunization. Medical history was hypertension, chronic atrial fib. Known allergies to contrast media (hives), possibly penicillin (rash as child). No other vaccine in four weeks. 40 hours after receiving vaccine, awoke with night sweats on 23Jan2021 03:00 AM. Felt find otherwise. Went back to sleep and fine in morning. No treatment. Outcome of the event was recovered. No covid prior vaccination. No covid tested post vaccination. No follow-up attempts are possible. No further information is expected.

Other Meds:

Current Illness:

ID: 1018981
Sex: M
Age:
State: MI

Vax Date: 01/18/2021
Onset Date: 01/20/2021
Rec V Date: 02/10/2021
Hospital:

Lab Data:

Allergies:

Symptoms: Second dose, massive diarrhea; severe fatigue; chills; diaphoretic; neck pain.; headache; This is a spontaneous report from a contactable Nurse (patient). A 50-years-old male patient received the second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) (lot number: EL3248) via an unspecified route of administration on 18Jan2021 at single dose in left arm for COVID-19 immunisation. He received the first dose (EL 3248) at age if 50-year-old on 28Dec2020 10:00 AM Intramuscular in Left arm for COVID-19 immunisation, and after first dose experienced nausea wanting to vomit, massive diarrhea, severe fatigue, with chills and diaphoresis, and bloody stool-diarrhea. Medical history included hypertension. There was no known allergies. Concomitant medication included acetaminophen. After the second dose, on 20Jan2021 10:00 PM the patient had massive diarrhea, severe fatigue, chills, diaphoretic, headache and neck pain. No treatment received for events. Events outcome was recovering.

Other Meds: ACETAMINOPHEN

Current Illness:

ID: 1018982
Sex: F
Age:
State: TX

Vax Date: 12/30/2020
Onset Date: 12/31/2020
Rec V Date: 02/10/2021
Hospital:

Lab Data:

Allergies:

Symptoms: pain at injection site from first dose; This is a spontaneous report from a contactable Nurse (patient). A 53-year-old female patient received the 1st dose of bnt162b2 (BNT162B2, Lot # either EJ7685 or EJ1685) at single dose at right deltoid on 30Dec2020 for Covid-19 immunisation. Medical history included gluten sensitivity and developed a rash when she ate gluten. The patient's concomitant medications were not reported. The patient experienced pain at injection site from 1st dose on 31Dec2020. The outcome of event was recovered on 02Jan2021. Information about Batch/Lot number has been requested.

Other Meds:

Current Illness:

ID: 1018983
Sex: F
Age:
State: CO

Vax Date: 01/16/2021
Onset Date: 01/16/2021
Rec V Date: 02/10/2021
Hospital:

Lab Data: Test Date: 20210116; Test Name: body temperature; Result Unstructured Data: Test Result:fever

Allergies:

Symptoms: FEVER; chills; aches and pain all over; Tiredness; received second dose on 16Jan2021, first dose on 31Dec2020; This is a spontaneous report received from a non-contactable other healthcare professional. A 30-year-old female patient received the second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number and expiry date unknown), intramuscular in the right arm, on 16Jan2021 08:30, at single dose, for COVID-19 immunization. The patient has known allergies to latex, bananas and adhesive. The patient was not pregnant at the time of vaccination. There were no concomitant medications (no other medications in two weeks). Historical vaccine included the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number and expiry date unknown), intramuscular in the right arm, on 31Dec2020 10:30, for COVID-19 immunization. The patient did not have other vaccines in four weeks. The patient did not have COVID-19 prior to vaccination and was not tested for COVID-19 post vaccination. The patient experienced fever, chills, aches and pain all over and tiredness on 16Jan2021 22:15. Treatment for the events was not given. The outcome of the events was unknown. No follow up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.

Other Meds:

Current Illness:

ID: 1018984
Sex: F
Age:
State:

Vax Date: 01/21/2021
Onset Date: 01/22/2021
Rec V Date: 02/10/2021
Hospital:

Lab Data: Test Date: 20210122; Test Name: Fever; Result Unstructured Data: Test Result:up to 102.5; Comments: 02:00; Test Date: 20210122; Test Name: heart rate; Result Unstructured Data: Test Result:racing; Comments: 02:00

Allergies:

Symptoms: Fever up to 102.5; nausea; dizziness; muscle aches; joint aches; headache; fatigue; weakness; heart rate racing; injection site pain; This is a spontaneous report from a non-contactable consumer (patient herself). A 47-year-old female patient (not pregnant) received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number EN5318), via an unspecified route of administration (left arm), on 21Jan2021 16:30, at single dose, for covid-19 immunization. The patient has no medical history and has no known allergies. The patient's concomitant medications were not reported. The patient experienced fever up to 102.5, nausea, dizziness, muscle aches, joint aches, headache, fatigue, weakness, heart rate racing, and injection site pain - all on 22Jan2021 02:00. No treatment was received for the events. The patient had not recovered from the events at the time of the report. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient did not have COVID prior vaccination and have not been COVID tested post vaccination. No follow-up attempts are possible. No further information is expected.

Other Meds:

Current Illness:

ID: 1018985
Sex: F
Age:
State: SC

Vax Date: 01/23/2021
Onset Date: 01/24/2021
Rec V Date: 02/10/2021
Hospital:

Lab Data:

Allergies:

Symptoms: Vomiting about 17 hours after shot; pressure in ears; aches; chills; This is a spontaneous report from a contactable other hcp reporting for herself. A 51-year-old female patient received the second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: EL9262), via an unspecified route of administration on the left arm on 23Jan2021 15:00 at a SINGLE DOSE for covid-19 immunisation. Medical history included vertigo from an unknown date and unknown if ongoing, food intolerance to raw eggs, red dye and bag lettuce from an unknown date and unknown if ongoing. Concomitant medication included ibuprofen (ADVIL [IBUPROFEN]) and paracetamol (TYLENOL). The patient previously had the first dose of the vaccine on 06Jan2021 (lot number: EK5730). On 24Jan2021 09:30 AM, the patient experienced vomiting about 17 hours after shot. Also, pressure in ears and like many others aches and chills. No treatment was received for the events. The outcome of the event was recovering.

Other Meds: ADVIL [IBUPROFEN]; TYLENOL

Current Illness:

ID: 1018986
Sex: F
Age:
State: CO

Vax Date: 01/22/2021
Onset Date: 01/23/2021
Rec V Date: 02/10/2021
Hospital:

Lab Data:

Allergies:

Symptoms: Complex Migraine and triggered trigeminal neuralgia event.; Complex Migraine and triggered trigeminal neuralgia event.; Complex Migraine and triggered trigeminal neuralgia event.; This is a spontaneous report from a contactable other healthcare professional. A 26-year-old female patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE lot number: el8982; expiry date: unknown) intramuscular in the right arm, on 22Jan2021 at 11:15, at a single dose, for COVID-19 immunisation. Medical history included ongoing trigeminal neuralgia and polycystic ovaries (PCOS). The patient had no known allergies. Concomitant medication included gabapentin. The previously received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE lot number: ek9231) intramuscular in the left arm, on 31Dec2020 at 10:30 AM for COVID-19 immunization. The patient is not pregnant at the time of vaccination. The patient was not diagnosed with COVID prior vaccination. The patient did not receive other vaccines within four weeks prior to COVID vaccination. The vaccine was administered in the hospital. On 23Jan2021 at 09:30, the patient experienced complex migraine and triggered trigeminal neuralgia event. The patient did not receive therapy for the events. Outcome of the events was recovered. The patient has not been tested for COVID-19 since vaccination.

Other Meds: GABAPENTIN

Current Illness: Trigeminal neuralgia

ID: 1018987
Sex: F
Age:
State: FL

Vax Date: 01/16/2021
Onset Date: 01/21/2021
Rec V Date: 02/10/2021
Hospital:

Lab Data:

Allergies:

Symptoms: extremely tiredness; Huge (8"X6") area of swollen red hot area; Huge (8"X6") area of swollen red hot area; Headache; itching; This is a spontaneous report from a contactable consumer (patient). A 73-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; lot number and expiry date were not reported), via an unspecified route of administration on 16Jan2021 12:00 at a single dose for COVID-19 immunization. Medical history included diabetic. Concomitant medication was not reported. Patient had no known allergies, was not pregnant and did not have COVID prior to vaccination. On 21Jan2021, the patient reported extreme tiredness, huge (8"x6") area of swollen red hot area, headache and itching. No treatment was received for the events. Patient has not been tested for COVID post-vaccination. Outcome of the events was not recovered. Information on the lot/batch number has been requested.

Other Meds:

Current Illness:

ID: 1018988
Sex: F
Age:
State: AZ

Vax Date: 01/14/2021
Onset Date: 01/14/2021
Rec V Date: 02/10/2021
Hospital:

Lab Data:

Allergies:

Symptoms: left ear ringing; bad headache; nauseous; no energy; I don't feel well; This is a spontaneous report from a contactable other healthcare professional (patient). A 63-year-old female patient received first dose BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; Lot number: Elo142), via an unspecified route of administration into the left arm on 14Jan2021 14:30 at a single dose for covid-19 immunisation. Medical history was reported as none. Patient was not pregnant. Concomitant medication included calcium (CALCIUM), vitamin d3 (VITAMIN D3) and monascus purpureus (RED YEAST RICE). On 14Jan2021, patient experienced bad headache, was nauseous, had no energy and was not feeling well. On 15Jan2021, patient also experienced left ear ringing. The patient received no treatment for the events reported. Outcome of events was recovering.

Other Meds: CALCIUM; VITAMIN D3; RED YEAST RICE

Current Illness:

ID: 1018989
Sex: F
Age:
State: FL

Vax Date: 01/18/2021
Onset Date: 01/18/2021
Rec V Date: 02/10/2021
Hospital:

Lab Data: Test Date: 20210118; Test Name: blood pressure; Result Unstructured Data: Test Result:90 over something; Test Date: 20210118; Test Name: blood pressure; Result Unstructured Data: Test Result:70 over 40 something; Test Date: 20210118; Test Name: blood pressure; Result Unstructured Data: Test Result:Ok; Test Date: 20210118; Test Name: heart rate; Result Unstructured Data: Test Result:Fine; Test Date: 20210118; Test Name: oxygen; Result Unstructured Data: Test Result:Fine

Allergies:

Symptoms: Got a bumpy itchy rash on both legs which is still present; sweating; arm began to hurt then throb and go numb a bit; arm began to hurt then throb and go numb a bit; The patient was cold; clammy; the first blood pressure was 90 over something/second blood pressure was 70 over 40 something; diarrhea; tired; This is a spontaneous report from a contactable consumer (patient). A 67-year-old female patient received the first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, lot number: 3247), via an unspecified route of administration in the left arm on 18Jan2021 10:00 at a single dose for COVID-19 immunization. The patient's medical history was none. There were no concomitant medications. The patient was not pregnant at the time of vaccination. The patient was not diagnosed with COVID-19 prior to vaccination and had not been tested for COVID-19 since the vaccination. On 18Jan2021 10:10, the patient's arm began to hurt then throb and go numb a bit. On 18Jan2021 10:15, the patient started sweating. She stood up to try and feel better. The patient's husband called the nurse over and they called the paramedics because they said the patient was cold, clammy, and still sweating. The patient sat down again and they put leads on me to check her heart rate, blood pressure (BP), and oxygen on 18Jan2021. Her heart rate and oxygen were fine but the first BP was 90 over something. A few minutes later, she closed her eyes and could have fallen asleep right there. Her second BP was 70 over 40 something. She opened up her eyes and tried to stand up again. After a few more minutes, her BP came up and was OK. They refused an ambulance and went home. She had diarrhea at home on 18Jan2021. She ate, walked and felt better. She just experienced the normal tired and hurt arm in the afternoon on 18Jan2021. She rested the balance of the day. On Wednesday (20Jan2021), she got a bumpy itchy rash on both legs which is still present but with cream, it was OK. No treatment was received for the adverse events. Outcome of the "the first blood pressure was 90 over something/second blood pressure was 70 over 40 something" was recovered on 18Jan2021 and of the remaining events was recovered on Jan2021.

Other Meds:

Current Illness:

ID: 1018990
Sex: M
Age:
State: WI

Vax Date: 01/23/2021
Onset Date: 01/23/2021
Rec V Date: 02/10/2021
Hospital:

Lab Data:

Allergies:

Symptoms: Fever; Headache; Joint pain; Chills; Vomiting; Fatigue; This is a spontaneous report from a contactable healthcare professional (patient). A 22-year-old male patient received the second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; Lot Number and Expiration Date were not reported), via an unspecified route of administration in right arm, on 23Jan2021 at 12:00 AM, at a single dose, for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. The patient previously took the first dose of BNT162B2 on 02Jan2021 at 04:45 PM for COVID-19 immunization (right arm). The patient was not diagnosed with COVID-19 prior to vaccination. No other vaccine was administered in four weeks. On 23Jan2021, the patient experienced fever, headache, joint pain, chills, vomiting, and fatigue. No treatment was received for the adverse events. The patient has not been tested for COVID-19 post-vaccination. The patient was recovering from the events. Information about lot number and expiration date for the suspect product will be requested in follow-up attempts.

Other Meds:

Current Illness:

ID: 1018991
Sex: F
Age:
State: CO

Vax Date: 01/16/2021
Onset Date: 01/17/2021
Rec V Date: 02/10/2021
Hospital:

Lab Data:

Allergies:

Symptoms: swelling in lymph node on left side of neck; Fatigue; headache; This is a spontaneous report from a contactable consumer (patient). A 34-year-old female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: EK9231), via an unspecified route of administration in left arm on 16Jan2021 13:45 at single dose for COVID-19 immunization. Medical history included ulcerative colitis and sulfa drug allergy from an unknown date and unknown if ongoing. Concomitant medication included mesalazine (APRISO), multivitamin and ergocalciferol (VIT D). The patient was not pregnant at time of vaccination. The patient experienced fatigue and headache on 17Jan2021 for two days. Eight days after vaccination on 24Jan2021, the patient experienced swelling in lymph node on left side of neck. The outcome of the events was not recovered. No treatment given to the patient for the events. The facility where the most recent COVID-19 vaccine was administered was in the Public Health Department. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient has not been tested for COVID-19.

Other Meds: Apriso; vitamin D

Current Illness:

ID: 1018992
Sex: F
Age:
State: CA

Vax Date: 01/20/2021
Onset Date: 01/20/2021
Rec V Date: 02/10/2021
Hospital:

Lab Data:

Allergies:

Symptoms: Fleeting mild headaches in recovery; 24 hours later, sudden tiredness; Nausea; Fierce diarrhea; Very sick for two hours; Muscle aches instead still there; This is a spontaneous report from a contactable consumer. An 80-year-old female patient started to receive bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration on 20Jan2021 13:15 at a single dose for COVID-19 immunization. Medical history included diabetic, Obese and COPD. The patient's concomitant medications were not reported. It was reported that the patient had fleeting mild headaches in recovery on 20Jan2021 13:30. 24 hours later, sudden tiredness. Two hours later nausea and then fierce diarrhea, very sick for two hours. Waited an hour, took a shower and went to bed. Fatigue and diarrhea lasted two more days but sick feeling gone. Muscle aches instead still there. The outcome of the event sickness was recovered in Jan2021, myalgia was not recovered while recovering for the remaining events. Information about batch/lot number has been requested.

Other Meds:

Current Illness:

ID: 1018993
Sex: M
Age:
State: IL

Vax Date: 01/22/2021
Onset Date: 01/22/2021
Rec V Date: 02/10/2021
Hospital:

Lab Data: Test Date: 20210122; Test Name: Body temperature; Result Unstructured Data: Test Result:102-103 degrees Fahrenheit

Allergies:

Symptoms: Fatigue; High fever (102-103 degrees F); severe body aches; head ache; This is a spontaneous report from a non-contactable other hcp (patient). A 38-year-old male patient received their second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; lot number and expiry date were not reported), via an unspecified route of administration on 22Jan2021 13:00 at single dose for COVID-19 immunization. Medical history included slight hypertension and acid reflux from an unknown date and unknown if ongoing. Concomitant medication included propranolol and lansoprazole (PREVACID). The patient previously received their first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; lot number and expiry date not reported) on 01Jan2021 at the age of 38 years for COVID-19 immunization. The patient experienced fatigue, high fever, severe body aches and head ache on 22Jan2021 21:00. The patient underwent lab tests and procedures which included body temperature: 102-103 degrees fahrenheit on 22Jan2021. The patient was recovering from the events. No follow-up attempts are possible. Information about lot/batch number cannot be obtained. No further information is expected.

Other Meds: Propranolol; Prevacid

Current Illness:

ID: 1018994
Sex: F
Age:
State: CA

Vax Date: 01/20/2021
Onset Date: 01/20/2021
Rec V Date: 02/10/2021
Hospital:

Lab Data:

Allergies:

Symptoms: Vomiting; Phlegm; Headache; Dizziness; This is a spontaneous report from a contactable consumer (patient). This 58-year-old female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) (Lot number unknown), via an unspecified route of administration at single dose in the left arm on 20Jan2021 14:00 for covid-19 immunisation. The patient medical history and concomitant medications were not reported. The patient previously took hydrocodone and experienced drug allergy. On 20Jan2021 15:00, the patient experienced vomiting, phlegm, headache, dizziness. No treatment required. The outcome of the events was recovered on an unspecified date in Jan2021.The patient had not had symptoms associated with COVID-19 prior vaccination. The patient had not been tested for COVID-19 post the vaccination. The patient was not pregnant at the time of vaccination. No follow-up attempts are possible. Information about lot/batch number cannot be obtained.

Other Meds:

Current Illness:

ID: 1018995
Sex: F
Age:
State: OR

Vax Date: 01/16/2021
Onset Date: 01/16/2021
Rec V Date: 02/10/2021
Hospital:

Lab Data:

Allergies:

Symptoms: 8-10 hrs post injection bad arm pain; with in 16-24 hours cold symptoms that are getting worse; we are now over a week a later and still runny nose; sore throat; This is a spontaneous report from a contactable healthcare professional (reporting for herself). A 47-year-old non-pregnant female patient received BNT162B2 (Pfizer-BioNTech COVID-19 mRNA vaccine, lot number: EL3246), at age 47 years, via an unspecified route of administration on the left arm, on 16Jan2021 13:15, at single dose, for COVID-19 vaccination. Medical history included low level diabetic, knee issues and milk allergy from an unspecified date. Patient had not had COVID prior to vaccination. Patient had not had other vaccine in four weeks. Concomitant medication included calcium (CALCIUM), fish oil (FISH OIL), glucosamine sulfate (GLUCOSAM), methylsulfonylmethane (MSM [METHYLSULFONYLMETHANE]), magnesium (MAGNESIUM) , cetirizine hydrochloride (ZYTREC) from unspecified dates. The patient previously took ASPRIN and was sensitive to it on an unspecified date. It was reported that on 16Jan2021 21:30, 8-10 hrs post injection bad arm pain, like yellow fever shot, then with in 16- 24 hours cold symptoms that are getting worse, at the time of report, over a week a later and still runny nose, and sore throat, no symptoms prior to shot. There was no treatment for the events. Patient was not tested for COVID post vaccination. Facility type vaccine: Doctor's office/urgent care. The outcome of the events was recovering.

Other Meds: CALCIUM; FISH OIL; GLUCOSAM; MSM [METHYLSULFONYLMETHANE]; MAGNESIUM; ZYTREC

Current Illness:

ID: 1018996
Sex: F
Age:
State: MO

Vax Date: 01/13/2021
Onset Date: 01/13/2021
Rec V Date: 02/10/2021
Hospital:

Lab Data:

Allergies:

Symptoms: Headache; fatigue; This is a spontaneous report from a contactable nurse (patient). A 44-year-old female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: EL8982), via an unspecified route of administration in right arm on 13Jan2021 08:45 at single dose for COVID-19 immunization. Medical history included penicillin allergy from an unknown date and unknown if ongoing. Concomitant medication included varenicline tartrate (CHANTIX), duloxetine hydrochloride (CYMBALTA), linaclotide (LINZESS), famotidine (PEPCID) and bupropion hydrochloride (WELLBUTRIN). The patient was not pregnant at time of vaccination. The facility where the most recent COVID-19 vaccine was administered was in the doctor's office/urgent care. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient has not been tested for COVID-19. The patient experienced headache and fatigue on 13Jan2021 12:00. The outcome of the events was recovered on unspecified date. No treatment was given to the patient for the events. No follow-up attempts are possible. No further information is expected.

Other Meds: CHANTIX; CYMBALTA; LINZESS; PEPCID [FAMOTIDINE]; WELLBUTRIN

Current Illness:

ID: 1018997
Sex: F
Age:
State: MI

Vax Date: 01/22/2021
Onset Date: 01/24/2021
Rec V Date: 02/10/2021
Hospital:

Lab Data:

Allergies:

Symptoms: Two days later I developed fever and shaking and headache; Two days later I developed fever and shaking and headache; Two days later I developed fever and shaking and headache; This is a spontaneous report from a contactable healthcare professional. A 47-year-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration on her left arm on 22Jan2021 09:00 at a single dose for COVID-19 immunization. The patient's medical history was not reported. Concomitant medication included terconazole, duloxetine hydrochloride (CYMBALTA), fluconazole. The patient reported that two days later, she developed fever and shaking and headache; all on 24Jan2021 11:00AM. No treatment was received for the events. The outcome of the events was not recovered. Information on the Batch/Lot number has been requested.

Other Meds: TERCONAZOLE; CYMBALTA; FLUCONAZOLE

Current Illness:

ID: 1018998
Sex: F
Age:
State:

Vax Date: 01/16/2021
Onset Date: 01/01/2021
Rec V Date: 02/10/2021
Hospital:

Lab Data:

Allergies:

Symptoms: muscle pain; red, warmth, and puffiness of injection site; red, warmth, and puffiness of injection site; red, warmth, and puffiness of injection site; This is a spontaneous report from a non-contactable consumer (patient). A 24-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration on 16Jan2021 at single dose for COVID-19 immunization. The patient was not pregnant at time of vaccination. Medical history included sulfa drug allergy and shellfish allergy from an unknown date and unknown if ongoing. There were no concomitant medications. It was reported that 1 week post vaccination, the patient experienced muscle pain and red, warmth, and puffiness of injection site in Jan2021. The outcome of the events was not recovered. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient has not been tested for COVID-19. No follow-up attempts are possible. Information about lot/batch number cannot be obtained. No further information is expected.

Other Meds:

Current Illness:

ID: 1018999
Sex: F
Age:
State:

Vax Date: 01/10/2021
Onset Date: 01/12/2021
Rec V Date: 02/10/2021
Hospital:

Lab Data: Test Date: 20210117; Test Name: Nasal Swab; Result Unstructured Data: Test Result:Negative

Allergies:

Symptoms: Developed rash. Started as 3 spots on lower abdomen, then over the course of the week developed more spots on abdomen, under left arm, under right breast, and on back.; They itch when touch; Patient developed rash/They are raised, erythematous spots with scaling in the middle; They are raised, erythematous spots with scaling in the middle; This is a spontaneous report from a contactable Other HCP (patient). A 28-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE Solution for injection lot no. EL3302, expiry date not reported), via an unspecified route of administration on left arm on 10Jan2021 at a single dose for covid-19 immunization. Medical history included pollen allergy. The patient was not pregnant. Concomitant medication included fluoxetine (FLUOXETINE), ethinylestradiol, ferrous fumarate, norethisterone acetate (HAILEY 24 FE); both on unspecified dates for unspecified indications. The patient had her first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE lot no. EJ1685, expiry date not reported) on 20Dec2020 on left arm for Covid-19 immunization. On 12Jan2021, the patient developed rash. Started as 3 spots on lower abdomen, then over the course of the week developed more spots on abdomen, under left arm, under right breast, and on back. They are raised, erythematous spots with scaling in the middle. They itch when touched. No ulceration, no oozing. The spots are larger and more red now than when it first began. The patient had nasal swab on 17Jan2021, and it was negative. Outcome of the events was not recovered. The vaccine was given on school or student health clinic. No other vaccines were given in four weeks. No follow-up attempts are possible. No further information is expected.

Other Meds: FLUOXETINE; HAILEY 24 FE

Current Illness:

ID: 1019000
Sex: F
Age:
State: NY

Vax Date: 01/01/2021
Onset Date: 01/22/2021
Rec V Date: 02/10/2021
Hospital:

Lab Data:

Allergies:

Symptoms: Soreness at injection site; This is a spontaneous report from a contactable other healthcare professional (patient). A 24-year-old female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE lot number: EL3247) via an unspecified route of administration on the left arm in Jan2021 at a single dose for COVID-19 immunization. The patient had no medical history. Concomitant medications were not reported (received within 2 weeks of vaccination). On 22Jan2021 17:00 the patient experienced soreness at injection site. No treatment was received for the event. The facility where the vaccine was administered was in a workplace clinic. Patient was not pregnant. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. Post vaccination, the patient has not been tested for COVID-19. No known allergies. Outcome of the event was recovered on an unspecified date.

Other Meds:

Current Illness:

ID: 1019001
Sex: F
Age:
State:

Vax Date:
Onset Date: 01/24/2021
Rec V Date: 02/10/2021
Hospital:

Lab Data:

Allergies:

Symptoms: Severe diarrhea; This is a spontaneous report from a non-contactable consumer (patient herself). A 46-years-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; lot number unknown), via an unspecified route of administration on unspecified date at SINGLE DOSE for COVID-19 immunisation. The patient medical history and concomitant medications were not reported. Patient did not have COVID-19 prior vaccination. The patient did not test for COVID-19 post vaccination. It was reported that the patient did not receive other vaccines in four weeks, "other vaccine same date details" were also provided as 24Jan2021 (as reported). The patient experienced severe diarrhea on 24Jan2021 12:30 which resulted in Emergency room/department or urgent care. Therapeutic measures were taken as a result of severe diarrhea. Outcome of the event was not recovered. No follow-up attempts are possible; Information on the lot/batch number cannot be obtained.

Other Meds:

Current Illness:

ID: 1019002
Sex: M
Age:
State: FL

Vax Date: 01/18/2021
Onset Date: 01/22/2021
Rec V Date: 02/10/2021
Hospital:

Lab Data: Test Date: 20210122; Test Name: temps; Result Unstructured Data: Test Result:ranging from 98.3-102.9; Comments: 10:00 thru the day and into bedtime

Allergies:

Symptoms: chills; shakes; Temps ranging from 98.3-102.9 thru the day and into bedtime.; Sweat profusely during the night waking often; Sweat profusely during the night waking often; Had difficulty breathing somewhat; This is a spontaneous report from a contactable consumer (patient). A 78-year-old male patient received the second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number EL1284), via an unspecified route of administration (left arm), on 18Jan2021 09:30, at single dose, for covid-19 immunization. The patient has no medical history and has no known allergies. Concomitant medications included rosuvastatin, and metoprolol succinate. The patient previously received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number EH9899), vaccine location left arm, on 28Dec2020 08:30 AM, for covid-19 immunization at a hospital at 78-years-old. Four days after the second injection, on 22Jan2021 10:00 mid-morning, the patient started with severe chills and shakes, temps ranging from 98.3-102.9 thru the day and into bedtime, sweat profusely during the night waking often, and had difficulty breathing somewhat. By mid-day the next day, the patient was without any more symptoms. The patient did not receive any treatment for these events. The patient recovered from the events on 23Jan2021. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient did not have COVID prior vaccination and have not been COVID tested post vaccination.

Other Meds: ROSUVASTATIN; METOPROLOL SUCCINATE

Current Illness:

ID: 1019003
Sex: M
Age:
State: MI

Vax Date: 01/23/2021
Onset Date: 01/24/2021
Rec V Date: 02/10/2021
Hospital:

Lab Data:

Allergies:

Symptoms: Achy; Headache; Throwing up; This is a spontaneous report from a contactable consumer. A 66-year-old male patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) on 23Jan2021 at single dose in left upper arm for COVID-19 immunisation at the age of 66-year-old. Lot number was EL3249. Medical history and Concomitant medications were none The patient woke up on 24Jan2021 morning and he felt like he was coming down with something. The achiness was first; it started early in the morning, then the headache was in the afternoon, and then at night he started throwing up. While the symptoms were developing, they were worsening, but since they started, they have stayed the same. On 24Jan2021, the patient experienced achy, headache, and threw up. The patient did not recover from the events.

Other Meds:

Current Illness:

Total 2021 VAERS Injuries: 134,999

Page last modified: 14 December 2021 10:42pm